[ET Net News Agency, 26 January 2024] WUXI XDC (02268) fell 16.2% to HK$26.4, dipping
below the 20-D SMA of HK$30.815.
It hits an intra-day low of HK$26.25, hitting a historical low, and an intra-day high of
HK$32. The total shares traded was 1.51 million, with a value of HK$43.49m. The active
buy/sell ratio is 39:61, with net selling turnover of HK$9.24m. GOLDMAN SACHS (ASIA) SEC
accounts for greatest net responsive buying turnover of HK$6.18m, with volume weighted
average price of HK$29.245. CITIGROUP GLOBAL accounts for greatest net responsive selling
turnover of HK$2.61m, with volume weighted average price of HK$28.278. The stock has
fallen a combined 17.2% over the past 2 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 26.400 % Chg -16.19%
High 32.000 Low 26.250
Shares Tr 1.51m Turnover 43.49m
10-D SMA 30.725 %H.V 67.726
20-D SMA 30.815 VWAP 28.735
50-D SMA - RSI14 38.153
----------------------------------
Status: Dipping below the 20-D SMA, hitting a historical low, active buy/sell ratio is
39:61, with net selling turnover of HK$9.24m, falling a combined 17.2% over the past 2
consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
WUXI XDC (02268) 26.40 -16.19
HUTCHMED (00013) 19.96 -7.16
GENSCRIPT BIO (01548) 14.16 -14.29
INNOVENT BIO (01801) 33.05 -8.19
EVEREST MED-B (01952) 16.90 -6.73
KEYMED BIO-B (02162) 31.75 -5.93
WUXI BIO (02269) 23.90 -20.33
BEIGENE (06160) 94.35 -2.38
AKESO (09926) 40.90 -7.26
REMEGEN (09995) 19.48 -7.24
---------------------------------------------
(ed)